Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity

BB Wu, KT Leung, ENY Poon - International journal of molecular sciences, 2022 - mdpi.com
Anthracyclines, such as doxorubicin, are effective chemotherapeutic agents for the treatment
of cancer, but their clinical use is associated with severe and potentially life-threatening …

Natural allies for heart health: Nrf2 Activation and cardiovascular disease management

SU Khan, SU Khan, M Suleman, MU Khan… - Current Problems in …, 2024 - Elsevier
The term “cardiovascular diseases”(CVD) refers to various ailments that affect the heart and
blood vessels, including myocardial ischemia, congenital heart defects, heart failure …

Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure

RRE Abouleisa, ABM Salama, Q Ou, XL Tang… - Circulation, 2022 - Am Heart Assoc
Background: The regenerative capacity of the heart after myocardial infarction is limited. Our
previous study showed that ectopic introduction of 4 cell cycle factors (4F; CDK1 [cyclin …

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review

G Georgiopoulos, N Makris, A Laina, F Theodorakakou… - Cardio Oncology, 2023 - jacc.org
Proteasome inhibitors (PIs) are the backbone of combination treatments for patients with
multiple myeloma and AL amyloidosis, while also indicated in Waldenström's …

Overexpression of Nfe2l1 increases proteasome activity and delays vision loss in a preclinical model of human blindness

Y Wang, A Snell, FM Dyka, ER Colvin, C Ildefonso… - Science …, 2023 - science.org
Proteasomes are the central proteolytic machines that are critical for breaking down most of
the damaged and abnormal proteins in human cells. Although universally applicable drugs …

Regulation and functions of the ER-associated Nrf1 transcription factor

G Ruvkun, N Lehrbach - Cold Spring Harbor …, 2023 - cshperspectives.cshlp.org
Nrf1 is a member of the nuclear erythroid 2-like family of transcription factors that regulate
stress-responsive gene expression in animals. Newly synthesized Nrf1 is targeted to the …

Mitochondrial quality control in lung diseases: current research and future directions

J Liu, J Wang, A Xiong, L Zhang, Y Zhang, Y Liu… - Frontiers in …, 2023 - frontiersin.org
Lung diseases are a major global health problem, affecting millions of people worldwide.
Recent research has highlighted the critical role that mitochondrial quality control plays in …

Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy

M Wehrens, AE de Leeuw, M Wright-Clark, JEC Eding… - Cell reports, 2022 - cell.com
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease that is characterized by
unexplained segmental hypertrophy that is usually most pronounced in the septum. While …

Regeneration of the heart: from molecular mechanisms to clinical therapeutics

QY Guo, JQ Yang, XX Feng, YJ Zhou - Military Medical Research, 2023 - Springer
Heart injury such as myocardial infarction leads to cardiomyocyte loss, fibrotic tissue
deposition, and scar formation. These changes reduce cardiac contractility, resulting in heart …

Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases

P Kiessling, C Kuppe - Genome Medicine, 2024 - Springer
Spatial multi-omic studies have emerged as a promising approach to comprehensively
analyze cells in tissues, enabling the joint analysis of multiple data modalities like …